NEW YORK (GenomeWeb News) – An anonymous donor has provided $500,000 to the Johns Hopkins Kimmel Cancer Center to advance its genomics-based screening test for ovarian and endometrial cancers, the cancer center announced on Thursday.

The sequencing-based test, called PapGene was developed by researchers at the Kimmel Center, and the gift will be used to conduct large-scale clinical trials and laboratory research on the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.